Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Melanoma 7Neuroendocrine Tumors 2Multiple Myeloma 2Neoplasms 1Neoplasm Metastasis 1Lymphoma, Follicular 1Lymphoma 1Liver Cirrhosis 1Hepatitis C 1Drug-Related Side Effects and Adverse Reactions 1Carcinoma, Hepatocellular 1

Interventions

telaprevir 1peginterferon alfa-2a 1hepatitis C immune globulin, human 1elbasvir-grazoprevir drug combination 1Ribavirin 1Introns 1Immunoglobulin G 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Hepatitis C × Introns × Clear all
NCT00273247 2006-01-09

Treatment With IFN After Curative Resection of HCC in HCV-Related Cirrhosis

National Cancer Institute, Milan

Phase 3 Completed
150 enrolled
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular, Liver Cirrhosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡